Ten stocks kicked off the trading week, booking losses, defying a broader market optimism, as investors began repositioning portfolios ahead of key events alongside a number of negative company-specific developments that sparked selling positions.

Meanwhile, Wall Street’s main indices all finished in the green, led by Nasdaq, up 1.37 percent, followed by the Dow Jones, jumping 1.12 percent, and the S&P 500, increasing 1.07 percent.

In this article, we focus on the performance of the 10 worst-performing stocks on Monday.

To come up with the list, we picked exclusively those with a $2 billion market capitalization and 5 million shares in trading volume.

10. Oracle Corp. (NYSE:ORCL)

Oracle dropped for a second day on Monday, shedding 4.85 percent to finish at $277.18 apiece, as investors took heart from an investment firm’s conservative rating, while repositioning portfolios ahead of its upcoming annual shareholders’ meeting.

In a market note, private banking firm Berenberg maintained its “neutral” rating and $306 price target for Oracle Corp. (NYSE:ORCL), marking a 10.4 percent upside potential from its latest closing price.

Meanwhile, Jefferies gave the company a “buy” recommendation with a price target of $400, or a 44 percent premium over its last closing price.

Jefferies’ coverage reflected Oracle Corp.’s (NYSE:ORCL) new five-year targets, with revenues of $225 billion and $21 in earnings per share, or a 31 percent and 28 percent compounded annual growth rate, respectively.

In other developments, Oracle Corp. (NYSE:ORCL) is set to hold its annual shareholders meeting on November 18, where investors will closely watch out for cues of more partnerships.

9. AppLovin Corp. (NASDAQ:APP)

AppLovin saw its share prices decline by 5.57 percent on Monday to finish at $565.94 apiece as investor sentiment was dampened by news that it is facing a new round of investigation, this time by multiple state attorneys general, over consumer data concerns.

A report by the New York Post over the weekend, citing unnamed sources, said that state regulators from Delaware, Oregon, and Connecticut have reached out to multiple short sellers as part of their preliminary investigations into AppLovin Corp. (NASDAQ:APP).

The probe apparently began in March and continued through the summer.

This followed the Securities and Exchange Commission’s own investigation of AppLovin Corp. (NASDAQ:APP), which was announced earlier this month, to similarly look into its data collection practices.

According to an earlier report by Bloomberg, the SEC was looking into allegations that the listed firm violated service agreements with its platform partners to deliver more targeted advertising to consumers.

For its part, AppLovin Corp. (NASDAQ:APP) said it engaged a law firm to investigate the allegations.

8. Quantum Computing Inc. (NASDAQ:QUBT)

Quantum Computing extended its losing streak to a 4th straight day on Monday, as investor funds shifted into the giant ones amid the start of the third quarter earnings season.

Quantum Computing Inc. (NASDAQ:QUBT) declined alongside its counterparts, namely Rigetti Computing Inc., IonQ Inc., and D-Wave Quantum Inc., suggesting that investor appetite for quantum computing stocks has tapered off and shifted to the country’s largest earners.

The quantum computing industry, on the other hand, remains a pre-profit sector despite rising valuations and government backing, relying mostly on a series of fundraising programs to ramp up business expansion.

For its part, Quantum Computing Inc. (NASDAQ:QUBT) recently raised $750 million in fresh funds from a private placement with institutional investors, covering more than 37.18 million shares.

Quantum Computing Inc. (NASDAQ:QUBT) said proceeds from the offer will be used to fund commercialization, pursue strategic acquisitions, establish volume production capabilities, expand sales and engineering personnel, as well as for working capital and other general corporate purposes.

7. ICICI Bank Ltd. (NYSE:IBN)

ICICI Bank dropped its share prices by 5.89 percent on Monday to close at $31 apiece as investors sold off positions after pricing in better-than-expected earnings performance in the second quarter of fiscal year 2026.

In an updated report last week, ICICI Bank Ltd. (NYSE:IBN) said net income after tax increased by 5 percent to 123.59 billion rupees from 11.7 billion rupees in the same period last year, bringing its six-month profit to 251.27 billion rupees.

Meanwhile, analysts compared by LSEG had expected a net profit of 122.36 billion rupees.

Net interest income grew by 7.4 percent to 215.29 billion rupees from 200.5 billion rupees in the same comparable period.

ICICI Bank Ltd. (NYSE:IBN) said the strong performance was buoyed by lower provisions against bad loans, which offset a fall in treasury income.

During the period, treasury income fell by 67.6 percent to 2.2 billion rupees from 6.8 billion rupees year-on-year.

6. Fermi Inc. (NASDAQ:FRMI)

Fermi Inc. saw its share prices decline by 5.96 percent on Monday to close at $25.39 apiece as investor sentiment was dampened by concerns for energy stocks tied to the AI bubble.

An opinion piece on the Wall Street Journal noted: “For all the fears about stretched technology shares, many of those companies are hugely profitable ones that will keep chugging along even if the artificial-intelligence boom doesn’t have legs. Not so in the energy sector.”

It said that a group of non-revenue-generating energy companies has collectively ballooned to more than $45 billion “in hopes that tech companies will one day pay for their yet-to-be-built power.”

For its part, Fermi Inc. (NASDAQ:FRMI) is a newly listed energy company that debuted only on the stock market last October 1, cashing in on the AI frenzy.

During its initial public offering, Fermi Inc. (NASDAQ:FRMI) was able to raise $682 million in fresh funds covering 32.5 million shares at a price of $21 apiece.

5. Critical Metals Corp. (NASDAQ:CRML)

Critical Metals declined by 6.14 percent on Monday to end at $19.58 apiece as investors took path from a former hedge fund manager’s recommendation to start cashing in on profits.

In the latest episode of Mad Money, host and former hedge fund manager Jim Cramer told a caller to start cashing in on Critical Metals Corp. (NASDAQ:CRML).

“It is time to [take profits in] Critical Metals. You need President Trump to go in there and buy 10 percent of the company—I don’t think it’s going to happen,” Cramer said.

Additionally, optimism for the stock tapered off after trade tensions between the US and China eased.

Critical Metals Corp. (NASDAQ:CRML) has been riding the geopolitical tensions over the past few weeks following China’s new policy to curb rare earth exports that fueled fears of another supply shortage. The curbs sparked optimism for US rare earth producers on expectations that the export restrictions would push customers to look elsewhere for supplies.

Rare earth metals are critical in the growth of the overall economy, as production of various industries, including semiconductors, aerospace, and automotive, heavily relies on the said minerals.

4. Rigetti Computing, Inc. (NASDAQ:RGTI)

Rigetti Computing fell for a third day on Monday, as investors sold off positions in quantum computing stocks to shift to the bigger earners amid the third quarter earnings season.

Rigetti Computing, Inc. (NASDAQ:RGTI) dropped alongside its counterparts, namely Quantum Computing Inc., IonQ Inc., and D-Wave Quantum Inc., suggesting that investor appetite for quantum computing stocks has tapered off and shifted to the country’s largest earners.

The quantum computing industry, on the other hand, remains a pre-profit sector despite rising valuations and government backing, relying mostly on a series of fundraising programs to ramp up business expansion.

In other developments, Rigetti Computing Inc. (NASDAQ:RGTI) recently received $5.7 million worth of new orders for its 9-qubit Novera computing system, ideal for pursuing research to better understand key areas of quantum computing, including how qubits operate, optimizing control systems, testing design, characterizing gates, mitigating decoherence, and developing more efficient quantum algorithms.

3. CoreWeave, Inc. (NASDAQ:CRWV)

CoreWeave, Inc. (NASDAQ:CRWV) fell for a second day on Monday, shedding 7.17 percent to finish at $127.06 apiece after the Institutional Shareholder Services (ISS) recommended to thumb down on the firm’s proposed merger with Core Scientific Inc.

The stance came despite Core Scientific’s Board of Directors saying that the proposed transaction represents the best available alternative for shareholders.

Earlier this year, Two Seas Capital—owner of approximately 6.5 percent of Core Scientific, Inc. (NASDAQ:CORZ), and also a shareholder of CoreWeave, Inc. (NASDAQ:CRWV)—said that the merger “leaves Core Scientific shareholders exposed to the high volatility of CoreWeave’s share price with no protections on the value they will receive at or following close.

The opposition created uncertainties around the transaction’s future, with the ISS’s stance potentially influencing institutional investors relying on proxy advisory services for voting guidance.

2. D-Wave Quantum Inc. (NYSE:QBTS)

D-Wave Quantum extended its losing streak to a third straight day on Monday, losing 10.25 percent to close at $34.40 apiece as investors sold off positions following the official redemption of its outstanding warrants.

In a statement, D-Wave Quantum Inc. (NYSE:QBTS) said that approximately 5 million warrants are currently outstanding and exercisable until November 19, 2025.

“If all of the outstanding warrants are exercised, approximately 7.2 million shares of common stock will be issued that will result in less than 2.1 percent dilution to existing shareholders,” D-Wave Quantum Inc. (NYSE:QBTS) said.

Meanwhile, any unexercised warrant will be redeemed for $0.01 apiece upon expiration, in accordance with the terms of the company’s warrant agreement.

In other news, D-Wave Quantum Inc. (NYSE:QBTS) said it recently partnered with Swiss Quantum Technology SA for the deployment of a D-Wave Advantage2 annealing quantum computer in Europe.

The agreement represents a 10 million euro commitment from Swiss Quantum, with an option to purchase the system.

1. Exelixis, Inc. (NASDAQ:EXEL)

Exelixis tumbled by 12 percent on Monday to close at $34.54 apiece as unimpressed investors soured on the results of its phase 3 trial for the study of Zanzalintinib for colon cancer.

In an updated report, Exelixis, Inc. (NASDAQ:EXEL) said the drug candidate—Zanzalintinib, in combination with atezolizumab—improved median overall survival to 10.9 months versus 9.4 months with regorafenib, significantly reducing the risk of death by 20 percent in the intention-to-treat population.

“While treating non-MSI-high metastatic colorectal cancer remains a challenge, the combination of zanzalintinib and atezolizumab has shown consistent benefits across key subgroups of patients,” said University of Pittsburgh Section Chief of Gastrointestinal Oncology Anwaar Saeed.

Exelixis, Inc. (NASDAQ:EXEL) EVP for Research and Development Dana Aftab said that the results from the latest clinical trial provide further insight into the combination of zanzalintinib and atezolizumab “as a potential new option” to extend survival in patients with the said type of cancer.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.